{"data":{"id":"us-ar/ark.-code-ann.-20-13-408","jurisdiction":"us-ar","citation":"Ark. Code Ann. § 20-13-408","heading":"Auto-injectable epinephrine use by an authorized entity","body":"(a) In order to ensure the public health and safety, an authorized entity that acquires auto-injectable epinephrine shall ensure that: (1) An expected user: (A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and (B) Obtains a certificate under this subchapter; (2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and (3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provider responding to the emergency. (b) An authorized entity and its expected users may: (1) Obtain a prescription in the name of the authorized entity for epinephrine auto-injectors and acquire epinephrine auto-injectors under the prescription; (2) Provide auto-injectable epinephrine for immediate self-administration to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has previously been diagnosed with an allergy; and (3) Administer auto-injectable epinephrine directly to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has been previously diagnosed with an allergy. (c) An authorized entity that possesses and makes available auto-injectable epinephrine shall: (1) (A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine. (B) The department annually shall publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and (2) Notify an agent of emergency communications, 911, or vehicle dispatch center of the existence, location, and type of auto-injectable epinephrine. Added by Act 2015, No. 1108,§ 4, eff. 7/22/2015.\n\n(a) In order to ensure the public health and safety, an authorized entity that acquires auto-injectable epinephrine shall ensure that: (1) An expected user: (A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and (B) Obtains a certificate under this subchapter; (2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and (3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provider responding to the emergency.\n\n(1) An expected user: (A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and (B) Obtains a certificate under this subchapter;\n\n(A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and\n\n(B) Obtains a certificate under this subchapter;\n\n(2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and\nns a certificate under this subchapter;\n\n(A) Completes appropriate knowledge and skills courses at least one (1) time every two (2) years in anaphylaxis and auto-injectable epinephrine use; and\n\n(B) Obtains a certificate under this subchapter;\n\n(2) The auto-injectable epinephrine is maintained according to the manufacturer's operational guidelines and instructions in a locked, secure location; and\n\n(3) A person who renders emergency care or treatment to a person having an anaphylactic reaction by using auto-injectable epinephrine activates the emergency medical services system as soon as possible and immediately reports the use of auto-injectable epinephrine to the medical provider responding to the emergency.\n\n(b) An authorized entity and its expected users may: (1) Obtain a prescription in the name of the authorized entity for epinephrine auto-injectors and acquire epinephrine auto-injectors under the prescription; (2) Provide auto-injectable epinephrine for immediate self-administration to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has previously been diagnosed with an allergy; and (3) Administer auto-injectable epinephrine directly to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has been previously diagnosed with an allergy.\n\n(1) Obtain a prescription in the name of the authorized entity for epinephrine auto-injectors and acquire epinephrine auto-injectors under the prescription;\n\n(2) Provide auto-injectable epinephrine for immediate self-administration to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has previously been diagnosed with an allergy; and\n\n(3) Administer auto-injectable epinephrine directly to an individual who the authorized entity or expected user believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for auto-injectable epinephrine or has been previously diagnosed with an allergy.\n\n(c) An authorized entity that possesses and makes available auto-injectable epinephrine shall: (1) (A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine. (B) The department annually shall publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and (2) Notify an agent of emergency communications, 911, or vehicle dispatch center of the existence, location, and type of auto-injectable epinephrine.\n\n(1) (A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine. (B) The department annually shall publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and\n\n(A) Submit to the Department of Health a report of each incident on the authorized entity's premises in which the authorized entity provides or administers auto-injectable epinephrine.\n\n(B) The department annually shall publish a report that summarizes and analyzes the reports submitted under this subdivision (c)(1); and\n\n(2) Notify an agent of emergency communications, 911, or vehicle dispatch center of the existence, location, and type of auto-injectable epinephrine.","path":["AR Code","Title 20","Chapter 13","Subchapter 4"],"source_url":"https://oss-data-us.vaquill.ai/v2026.08/us_ar_statutes.parquet","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:41Z","sha256":"02196b598b2ec0dd3860508d980f8de09580effb596c180b337b39a38b0148af","source_id":"us-ar","stale":false,"prev":"us-ar/ark.-code-ann.-20-13-407","next":"us-ar/ark.-code-ann.-20-13-501"},"notice":"GroundRules: Original legal text. Not legal advice."}